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Short Communication
Effect of ampicillin-sulbactam on clinical capillary zone
electrophoresis of serum proteins
Figure 1 Effect of ampicillin-sulbactam on serum CZE.
CZE electropherograms show (A) a patient sample taken dur-
ing infusion of 2 g of ampicillin and 1 g of sulbactam and
(B) a patient sample 2 days later, and (C) a random normal
serum sample supplemented with 3 g/L ampicillin-
sulbactam.
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Abstract
Background: Capillary zone electrophoresis (CZE) is a
well-accepted automated method used to separate
serum proteins and detect monoclonal components.
CZE uses ultraviolet detection at 214 nm to directly
quantify proteins via peptide bonds. Any substance
that absorbs at 214 nm and is present in serum can
potentially interfere with CZE analysis. This has been
reported for radio-contrast media and antibiotics.
Methods: Here we describe a peak on the anode side
of the a2-globulin fraction caused by the antibiotic
ampicillin-sulbactam (Unacid).
Results and conclusions: Extra peaks that can be mis-
interpreted as monoclonal components can be pres-
ent in almost all electrophoretic fractions of CZE.
Immunosubtraction or immunofixation is always
required to rule out these conditions.
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Capillary zone electrophoresis (CZE) has emerged as
a well-accepted automated method to separate serum
proteins and detect monoclonal components in clini-
cal laboratories (1, 2). CZE is not dependent on dye
binding. Instead it uses ultraviolet detection at 214 nm
to directly quantify proteins via peptide bonds, in con-
trast to conventional electrophoretic methods. How-
ever, any substance or drug that is present in serum
and that absorbs at 214 nm can potentially interfere
with CZE analysis. This has been reported for radio-
contrast media, which can simulate a monoclonal
component (3). Abnormal peaks have also been
observed with antibiotics such as piperacillin-tazobac-
tam (anode side of the b-globulin fraction) (4) and sul-
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famethoxazole (anode side of the albumin fraction) (5).
Here we describe a peak at the anode side of the a2-
globulin fraction caused by the antibiotic ampicillin-
sulbactam (Unacid, Pfizer Pharma GmbH, Karlsruhe,
Germany).
During daily protein electrophoresis analysis on a
Paragon CZE 2000 system (Beckman-Coulter, Brea,
CA, USA; Version 2.0.14) a patient sample presented
with an extremely sharp peak at the anode side of the
a2-globulin fraction (Figure 1A). Subsequent conven-
tional dye-based protein electrophoresis showed no
peak. Neither immunosubtraction on the Paragon CZE
2000 nor additional immunofixation (Paragon IFE,
Beckman-Coulter) detected a monoclonal component,
and thus a non-protein compound was suspected.
The ward reported that the sample was taken while
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the patient was receiving an ampicillin-sulbactam
infusion. A sample from the same patient taken 2
days later showed no sign of this peak (Figure 1B).
Moreover, addition of ampicillin-sulbactam to a ran-
dom normal serum sample at various concentrations
(0.3–3 g/L) produced a similar, dose-dependent peak
at the same location as for the original patient sample
(Figure 1C). Further studies revealed that the peak
was caused by ampicillin.
This case confirms that substances other than pro-
teins that absorb at 214 nm interfere in CZE and pres-
ent as extra peaks (3). This has been reported for the
antibiotics piperacillin-tazobactam (0.9 g/L) (4) and
sulfamethoxazole (0.24 g/L) (5). The extra peak caused
by ampicillin-sulbactam (0.3–3 g/L) is located on the
anode side of the a2-globulin fraction and thus could
be misinterpreted as a monoclonal component. In
summary, different pharmaceuticals can produce
extra peaks in almost all CZE fractions (3) and could
be suspected or misinterpreted as monoclonal com-
ponents. Thus, immunosubtraction or immunofix-
ation is always required to rule out these conditions.
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